XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery

XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery

Normal and fibrotic NativeCoat™ ECM substrates increase predictiveness of high throughput compound screening